Criticalkare Pharma

Xarelto 2.5mg tablet contains the active ingredient Rivaroxaban. It is an anticoagulant that belongs to the Xa inhibitors. It treats deep vein thrombosis (DVT, a blood clot present usually in the leg) and pulmonary embolism (PE, a blood clot in the lung) in adults. It also prevents DVT and PE from reoccurring after initial treatment in adults. It is also used to help prevent strokes or serious blood clots in adults who have atrial fibrillation (a condition in which the heart beats irregularly, increasing the chance of clots forming in the body and possibly causing strokes) that is not caused by heart valve disease.
Xarelto 2.5mg tablet is also indicated in children and adolescents below 18 years and with a body weight of 30kg or more to treat blood clots. It is also used to prevent the re-occurrence of blood clots in the veins or the blood vessels of the lungs, following initial treatment of at least 5 days with injectable medicines used to treat blood clots. Do not take this medicine if you are allergic to rivaroxaban or any of the other ingredients of this medicine. Do not take this medicine if you are bleeding excessively. Do not take this medicine if you have a disease or condition in an organ that increases the risk of serious bleeding.

Uses
Treatment of Stroke.Prevention of blood clots in veins after hip or knee replacement operation.Treatment of blood clots in Deep vein thrombosis, Systemic embolism and Pulmonary embolism.

Storage
Store at 25°C

Side Effects
GastroenteritisVomitingCoughFeverDecreased general strength and energyPain in the limbsHeart problemsSevere skin rashesExcessive bleeding

Xarelto 10mg tablet contains the active ingredient Rivaroxaban. It is an anticoagulant that belongs to the Xa inhibitors. It treats deep vein thrombosis (DVT, a blood clot present usually in the leg) and pulmonary embolism (PE, a blood clot in the lung) in adults. It also prevents DVT and PE from reoccurring after initial treatment in adults. It is also used to help prevent strokes or serious blood clots in adults who have atrial fibrillation (a condition in which the heart beats irregularly, increasing the chance of clots forming in the body and possibly causing strokes) that is not caused by heart valve disease.
Xarelto 10mg tablet is also indicated in children and adolescents below 18 years and with a body weight of 30kg or more to treat blood clots. It is also used to prevent the re-occurrence of blood clots in the veins or the blood vessels of the lungs, following initial treatment of at least 5 days with injectable medicines used to treat blood clots. Do not take this medicine if you are allergic to rivaroxaban or any of the other ingredients of this medicine. Do not take this medicine if you are bleeding excessively. Do not take this medicine if you have a disease or condition in an organ that increases the risk of serious bleeding.

Uses
Treatment of StrokePrevention of blood clots in veins after hip or knee replacement operation.Treatment of blood clots in Deep vein thrombosis, Systemic embolism and Pulmonary embolism

Storage
Store at 25°C

Side Effects
GastroenteritisVomitingCoughFeverDecreased general strength and energyPain in the limbsHeart problemsSevere skin rashesExcessive bleeding

Xarelto 15mg tablet contains the active ingredient Rivaroxaban. It is an anticoagulant that belongs to the Xa inhibitors. It treats deep vein thrombosis (DVT, a blood clot present usually in the leg) and pulmonary embolism (PE, a blood clot in the lung) in adults. It also prevents DVT and PE from reoccurring after initial treatment in adults. It is also used to help prevent strokes or serious blood clots in adults who have atrial fibrillation (a condition in which the heart beats irregularly, increasing the chance of clots forming in the body and possibly causing strokes) that is not caused by heart valve disease.
Xarelto 15mg tablet is also indicated in children and adolescents below 18 years and with a body weight of 30kg or more to treat blood clots. It is also used to prevent the re-occurrence of blood clots in the veins or the blood vessels of the lungs, following initial treatment of at least 5 days with injectable medicines used to treat blood clots. Do not take this medicine if you are allergic to rivaroxaban or any of the other ingredients of this medicine. Do not take this medicine if you are bleeding excessively. Do not take this medicine if you have a disease or condition in an organ that increases the risk of serious bleeding.

Uses
Treatment of StrokePrevention of blood clots in veins after hip or knee replacement operation.Treatment of blood clots in Deep vein thrombosis, Systemic embolism and Pulmonary embolism

Storage
Store at 25°C

Side Effects
GastroenteritisVomitingCoughFeverDecreased general strength and energyPain in the limbsHeart problemsSevere skin rashesExcessive bleeding

Xarelto 20mg tablet contains the active ingredient Rivaroxaban. It is an anticoagulant that belongs to the Xa inhibitors. It treats deep vein thrombosis (DVT, a blood clot present usually in the leg) and pulmonary embolism (PE, a blood clot in the lung) in adults. It also prevents DVT and PE from reoccurring after initial treatment in adults. It is also used to help prevent strokes or serious blood clots in adults who have atrial fibrillation (a condition in which the heart beats irregularly, increasing the chance of clots forming in the body and possibly causing strokes) that is not caused by heart valve disease.
Xarelto 20mg tablet is also indicated in children and adolescents below 18 years and with a body weight of 30kg or more to treat blood clots. It is also used to prevent the re-occurrence of blood clots in the veins or the blood vessels of the lungs, following initial treatment of at least 5 days with injectable medicines used to treat blood clots. Do not take this medicine if you are allergic to rivaroxaban or any of the other ingredients of this medicine. Do not take this medicine if you are bleeding excessively. Do not take this medicine if you have a disease or condition in an organ that increases the risk of serious bleeding.

Uses
Treatment of StrokePrevention of blood clots in veins after hip or knee replacement operation.Treatment of blood clots in Deep vein thrombosis, Systemic embolism and Pulmonary embolism

Storage
Store at 25°C

Side Effects
GastroenteritisVomitingCoughFeverDecreased general strength and energyPain in the limbsHeart problemsSevere skin rashesExcessive bleeding

Tenectase 20mg Injection belongs to the antiplatelet agent category, containing the active ingredient Tenecteplase. It is used to prevent blood clots in patients with acute coronary syndrome (ACS), including unstable angina or myocardial infarction (heart attack).
This drug is contraindicated in individuals with known hypersensitivity or allergic reactions to other ingredients in it. If you are scheduled for surgery (including dental work), it is important to inform your doctor. Due to the increased risk of bleeding associated with Tenectase 20mg Injection, your physician may advise you to stop taking the medication five days prior to the surgery.  If you develop irregular breathing patterns such as speeding up, slowing down, or experiencing short pauses in breathing, it is recommended to consult your doctor for further evaluation.

Uses
Prevent blood clots in patients with acute coronary syndrome (ACS)   

Storage
Do not store Tenectase 20mg Injection above (30°C). 

Side Effects
Shortness of breathBlood clotting problem called TTP (purplish spots in the mouth or mouth, fever, confusion, yellowing of the eyes or skin, fever)FaintingBleeding (red or black stools, coughing up or vomiting with blood, red, pink, or brown urine)HeadacheIndigestionNauseaConstipationRash, itchingPain and swelling in the jointsBlurred visionBleeding gumsBruising

Fragmin 2500IU Injection contains an active component as dalteparin. It is a medication used to prevent and treat blood clots. It is a type of anticoagulant, specifically a low molecular weight heparin (LMWH). This medication works by inhibiting the formation of blood clots, which can help reduce the risk of conditions like deep vein thrombosis (DVT) and pulmonary embolism. Deep vein thrombosis (DVT) is a blood clot that forms in a deep vein, usually in the legs. At the same time, pulmonary embolism is a serious condition that occurs when a clot travels to the lungs, potentially causing life-threatening complications.
Fragmin 2500IU Injection has a more predictable anticoagulant response than unfractionated heparin, allowing for easier dosing and monitoring. It has a longer half-life, which means less frequent dosing is required compared to other anticoagulants, leading to better patient compliance. Unlike warfarin, which requires frequent international normalized ratio (INR) level monitoring, this medication typically does not need such monitoring. This medication has a lower bleeding risk than other anticoagulants, making them safer for certain patient populations.

Uses
Deep vein thrombosis (DVT)Pulmonary embolism (PE)Prevention of blood clots in medical setting

Storage
Store at room temperature, between 20°C to 25°C (68°F to 77°F).

Side Effects
Signs of bleedingBlack or bloody stoolsCoughing up blood or blood clotsSevere headache or weakness, especially on one side of the bodySudden vision changesSevere abdominal or back painSevere or persistent dizziness or faintingSigns of an allergic reaction, including rash, itching, swellingBruising at the injection siteMild pain or redness at the injection siteBleeding from the gums or noseMild stomach upset or nauseaMild headacheItching or skin rash

Fragmin 10000IU Injection contains an active component as dalteparin. It is a medication used to prevent and treat blood clots. It is a type of anticoagulant, specifically a low molecular weight heparin (LMWH). This medication works by inhibiting the formation of blood clots, which can help reduce the risk of conditions like deep vein thrombosis (DVT) and pulmonary embolism. Deep vein thrombosis (DVT) is a blood clot that forms in a deep vein, usually in the legs. At the same time, pulmonary embolism is a serious condition that occurs when a clot travels to the lungs, potentially causing life-threatening complications.
Fragmin 10000IU Injection has a more predictable anticoagulant response than unfractionated heparin, allowing for easier dosing and monitoring. It has a longer half-life, which means less frequent dosing is required compared to other anticoagulants, leading to better patient compliance. Unlike warfarin, which requires frequent international normalized ratio (INR) level monitoring, this medication typically does not need such monitoring. This medication has a lower bleeding risk than other anticoagulants, making them safer for certain patient populations.

Uses
Deep vein thrombosis (DVT)Pulmonary embolism (PE)Prevention of blood clots in medical setting

Storage
Store at room temperature, between 20°C to 25°C (68°F to 77°F).

Side Effects
Signs of bleedingBlack or bloody stoolsCoughing up blood or blood clotsSevere headache or weakness, especially on one side of the bodySudden vision changesSevere abdominal or back painSevere or persistent dizziness or faintingSigns of an allergic reaction, including rash, itching, swellingBruising at the injection siteMild pain or redness at the injection siteBleeding from the gums or noseMild stomach upset or nauseaMild headacheItching or skin rash

Fragmin 10000IU Injection contains an active component as dalteparin. It is a medication used to prevent and treat blood clots. It is a type of anticoagulant, specifically a low molecular weight heparin (LMWH). This medication works by inhibiting the formation of blood clots, which can help reduce the risk of conditions like deep vein thrombosis (DVT) and pulmonary embolism. Deep vein thrombosis (DVT) is a blood clot that forms in a deep vein, usually in the legs. At the same time, pulmonary embolism is a serious condition that occurs when a clot travels to the lungs, potentially causing life-threatening complications.
Fragmin 10000IU Injection has a more predictable anticoagulant response than unfractionated heparin, allowing for easier dosing and monitoring. It has a longer half-life, which means less frequent dosing is required compared to other anticoagulants, leading to better patient compliance. Unlike warfarin, which requires frequent international normalized ratio (INR) level monitoring, this medication typically does not need such monitoring. This medication has a lower bleeding risk than other anticoagulants, making them safer for certain patient populations.

Uses
Deep vein thrombosis (DVT)Pulmonary embolism (PE)Prevention of blood clots in medical setting

Storage
Store at room temperature, between 20°C to 25°C (68°F to 77°F).

Side Effects
Signs of bleedingBlack or bloody stoolsCoughing up blood or blood clotsSevere headache or weakness, especially on one side of the bodySudden vision changesSevere abdominal or back painSevere or persistent dizziness or faintingSigns of an allergic reaction, including rash, itching, swellingBruising at the injection siteMild pain or redness at the injection siteBleeding from the gums or noseMild stomach upset or nauseaMild headacheItching or skin rash

Cytosorb device is a medical device used in critical care settings to remove inflammatory mediators from the bloodstream of patients with conditions such as sepsis, acute respiratory distress syndrome (ARDS), and cardiac surgery-associated inflammatory response syndrome (CARS). The body can produce excessive levels of cytokines in inflammation due to severe infection. This device removes these cytokine substances in your blood.
Cytosorb devices are used to treat patients aged 18 years and above with confirmed COVID-19 who are showing certain severe symptoms (including a persistent cough, high fever, developing more difficulty breathing). COVID-19 is a highly infectious disease caused by the SARS-CoV-2 virus. It is essential to inform your health care professional if you are pregnant or have any diseases or allergic conditions before starting treatment with Cytosorb devices.

Uses
Treatment of COVID-19 patients with severe symptomsAcute respiratory distress syndrome (ARDS)Cardiac surgery-associated inflammatory response syndrome (CARS)

Storage
Store at a cool temperature of 4°C and 30°C (39°F and 86°F).Do not freeze.Protected from light.Keep it in its original packaging until it is ready to be used.  
Should be disposed of properly.

Side Effects 
Very low blood pressureAbnormal heart rhythmBleedingBlood clottingLow platelet downLow levels of calcium and proteins in the bloodInfectionAllergic reactionsSepsisAnaphylactic shockHypotensionFeverDizzinessLightheadednessFainting